ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
PAR - 50% REDUCTION IN OSTEOARTHRITIS PAIN MAINTAINED
Published: 15/06/18, 08:29am (AEST)•3 pages